Literature DB >> 8664136

Prognostic factors and survival in a heterogeneous sample of cancer patients.

G I Ringdal1, K G Götestam, S Kaasa, S Kvinnsland, K Ringdal.   

Abstract

This study examines the prognostic value of clinical assessments, including a 3-fold classification of cancer patients by treatment intention. It is based upon a sample of 253 patients with different cancer diagnoses who filled out a 108-item questionnaire. Cox regression analysis (the proportional hazards model) was used to analyse the relationship of the three groups of covariates (clinical, demographic and psychosocial) with survival. The univariate analysis showed that several clinical, demographic and psychosocial covariates are significantly related to survival. The study located two main prognostic factors: the 3-fold classification by treatment intention being the most important one, followed by physical functioning which may be seen as a proxy for performance status. Several additional covariates including psychosocial ones were related to survival when considered separately. However, their effects disappeared when controlling for treatment intention and physical functioning. Thus, the additional psychosocial covariates did no add to the prognostic value of the model.

Entities:  

Mesh:

Year:  1996        PMID: 8664136      PMCID: PMC2074532          DOI: 10.1038/bjc.1996.300

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Psychological response to breast cancer and 15-year outcome.

Authors:  S Greer; T Morris; K W Pettingale; J L Haybittle
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

Review 2.  Measurement of quality of life in advanced breast cancer.

Authors:  M Baum; S R Ebbs; L J Fallowfield; S C Fraser
Journal:  Acta Oncol       Date:  1990       Impact factor: 4.089

3.  Effect of psychosocial treatment on survival of patients with metastatic breast cancer.

Authors:  D Spiegel; J R Bloom; H C Kraemer; E Gottheil
Journal:  Lancet       Date:  1989-10-14       Impact factor: 79.321

4.  The measurement of pessimism: the hopelessness scale.

Authors:  A T Beck; A Weissman; D Lester; L Trexler
Journal:  J Consult Clin Psychol       Date:  1974-12

5.  The relationship between different staging methods and survival in colorectal carcinoma.

Authors:  P H Chapuis; R Fisher; O F Dent; R C Newland; M T Pheils
Journal:  Dis Colon Rectum       Date:  1985-03       Impact factor: 4.585

6.  Prognostic factors in rectal carcinoma. A contribution to the further development of tumor classification.

Authors:  P Hermanek; I Guggenmoos-Holzmann; F P Gall
Journal:  Dis Colon Rectum       Date:  1989-07       Impact factor: 4.585

7.  Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. The importance of patients' subjective experience of disease and psychosocial well-being.

Authors:  S Kaasa; A Mastekaasa; E Lund
Journal:  Radiother Oncol       Date:  1989-07       Impact factor: 6.280

8.  Psychosocial correlates of cancer survival: a subsequent report 3 to 8 years after cancer diagnosis.

Authors:  B R Cassileth; W P Walsh; E J Lusk
Journal:  J Clin Oncol       Date:  1988-11       Impact factor: 44.544

9.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

10.  Prognostic factors for survival in patients with inoperable lung cancer.

Authors:  K E Stanley
Journal:  J Natl Cancer Inst       Date:  1980-07       Impact factor: 13.506

View more
  14 in total

1.  A follow-up study of the quality of life in cancer patients with different prognoses.

Authors:  G I Ringdal; K Ringdal
Journal:  Qual Life Res       Date:  2000-02       Impact factor: 4.147

2.  Development of a computer-administered mobility questionnaire.

Authors:  Jorunn L Helbostad; Line M Oldervoll; Peter M Fayers; Marit S Jordhøy; Kenneth C H Fearon; Florian Strasser; Stein Kaasa
Journal:  Support Care Cancer       Date:  2010-03-26       Impact factor: 3.603

Review 3.  Influence of psychological coping on survival and recurrence in people with cancer: systematic review.

Authors:  Mark Petticrew; Ruth Bell; Duncan Hunter
Journal:  BMJ       Date:  2002-11-09

Review 4.  Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress.

Authors:  Laura A A Gilliam; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2011-06-15       Impact factor: 8.401

5.  Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population.

Authors:  T Sokka; A Häkkinen; E Krishnan; P Hannonen
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

6.  Depression and cancer mortality: a meta-analysis.

Authors:  M Pinquart; P R Duberstein
Journal:  Psychol Med       Date:  2010-01-20       Impact factor: 7.723

Review 7.  Associations of social networks with cancer mortality: a meta-analysis.

Authors:  Martin Pinquart; Paul R Duberstein
Journal:  Crit Rev Oncol Hematol       Date:  2009-07-14       Impact factor: 6.312

8.  Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.

Authors:  Chan Joo Yang; Jong-Lyel Roh; Min-Ju Kim; Sang-wook Lee; Sung-Bae Kim; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Qual Life Res       Date:  2015-07-09       Impact factor: 4.147

9.  Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials.

Authors:  Franck Bonnetain; Xavier Paoletti; Sandra Collette; Michel Doffoel; Olivia Bouché; Jean Luc Raoul; Philippe Rougier; Fadil Masskouri; Jean Claude Barbare; Laurent Bedenne
Journal:  Qual Life Res       Date:  2008-07-10       Impact factor: 4.147

Review 10.  Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.

Authors:  Ali Montazeri
Journal:  Health Qual Life Outcomes       Date:  2009-12-23       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.